Publications
Where expertise meets impact
Berry doesn’t just follow industry standards — we set them. Our team of award-winning statisticians, journal editors, and regulatory advisors leads the field in Bayesian and adaptive trial design. With research published in The New England Journal of Medicine, JAMA, and The Lancet, we’re driving innovation where it matters most.
Over 90% of our scientists published influential work this past year, advancing adaptive, Bayesian, and platform trial methodology. Our blend of academic rigor, regulatory insight, and real-world experience makes Berry a true authority in modern clinical trials.
Explore our most impactful peer-reviewed publications below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Neuro-Oncology
Oncology
Platform
CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
November 11, 2024
2024
doi: 10.1093/neuonc/noad137.263
Neuro-Oncology
Oncology
Platform
LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
November 11, 2024
2024
DOI: 10.1093/neuonc/noae165.1302
American Heart Association Journal
Neuroscience
Stroke
Adaptive Clinical Trials in Stroke
October 22, 2024
2024
DOI: 10.1161/STROKEAHA.124.046125
Journal of Cardiac Failure
Methodology
Stopping Rules
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in "Negative" Clinical Trials
October 4, 2024
2024
DOI: 10.1016/j.cardfail.2024.09.007
Clinical Infectious Disease
Infectious Disease
Platform
Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled Trial
September 26, 2024
2024
doi: 10.1093/cid/ciae289
JAMA
Neuroscience
Enrichment
Writing Committee for the TESLA Investigators; Yoo AJ et al. Thrombectomy for Stroke With Large Infarct on Noncontrast CT: The TESLA Randomized Clinical Trial.
September 24, 2024
2024
doi: 10.1001/jama.2024.13933
The New England Journal of Medicine
Neuroscience
Other
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
September 5, 2024
2024
doi: 10.1056/NEJMoa2314779.
Journal Of Infection
Infectious Disease
Platform
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
August 29, 2024
2024
DOI: 10.1016/j.jinf.2024.106248
No results found.
There are no results with this criteria. Try changing your search.